The LIRA-RENAL Trial (Once-Daily Liraglutide) The Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL) trial investigated the efficacy and safety of liraglutide as an add-on to existing glucose-lowering medications in people with inadequately controlled T2DM and moderate renal impairment (stage 3 CKD, eGFR 3059 ml/min/1.73 m 2 ) [48]
Government of Canada, The Daily The prevalence of overweight and obesity is on the rise in Canada: New results from the Canadian Health Measures Survey, 2022 to 2024. Accessed: Nov
transparency between your weight loss therapy team and your surgical team reduces complications and speeds your safe return to treatment after healing
How Does Semaglutide Help Burn Belly Fat
What to Keep in Your Kitchen Stock your kitchen with foods you know work for you
The authors determined significantly higher concentrations of semaglutide in the hypothalamus compared to other parts of the brain, indicating that the drug effectively reaches regions associated with the GLP-1 receptor, which are related to appetite suppression and neuroprotection
